News
Here’s the latest news from J&J Tech.
Incheon Creative Economy Innovation Center Investment Company "J&J Tech" Selected Ministry of SMEs and Startups Tips
Author
관리자
Date
2023-12-27 12:32
Views
452
https://www.greenpostkorea.co.kr/news/articleView.html?idxno=211487
The Incheon Creative Economy Innovation Center (hereinafter referred to as the Incheon Center) announced on the 13th that J&J Tech, an investment company that the center invested in, was finally selected for the TIPS program.
Tips is a technology start-up support program promoted by the government and the private sector in cooperation to discover and foster start-ups with technological skills. If the private sector makes initial investments in companies, the Ministry of SMEs and Startups will support R&D funds.
J&J Tech, which was selected for the program, will be able to receive up to 500 million won from the Ministry of SMEs and Startups for research and development and marketing over the next two years. This was done with the investment of the Incheon Intellectual Property No. 2 Fund, which was created with the support of the Incheon Metropolitan Government, and the recommendation of the Incheon Center, the tip operator.
J&J Tech is a company based in Incheon, and CEO Cho Sung-hoon developed a drug recognition and inventory management solution to solve the difficulties of drug inventory management that pharmacists are experiencing in the field based on his experience as a pharmacist for 10 years.
Based on this, the company has developed a drug manager app that utilizes artificial intelligence (AI) object recognition technology. The app provides drug count, return and inventory management services, and has attracted more than 10,000 customers in just three months after its launch. The Incheon Setter explained that J&J Tech's selection of the tips is the result of recognizing the capabilities of such a drug total management solution technology.
"Based on this selection of tips, we will focus more on developing solutions aimed at improving the efficiency of pharmacy work in the future," said Cho Sung-hoon, CEO of J&J Tech. "This will soon help patients and their caregivers' safety and health, and we will provide services that can be applied to the global market in the future."
Lee Han-seop, head of the Incheon Center, said, "The center judged that J&J Tech has the potential to grow into a global start-up company in the current situation where the size of the drug market continues to expand due to aging."
The Incheon Creative Economy Innovation Center (hereinafter referred to as the Incheon Center) announced on the 13th that J&J Tech, an investment company that the center invested in, was finally selected for the TIPS program.
Tips is a technology start-up support program promoted by the government and the private sector in cooperation to discover and foster start-ups with technological skills. If the private sector makes initial investments in companies, the Ministry of SMEs and Startups will support R&D funds.
J&J Tech, which was selected for the program, will be able to receive up to 500 million won from the Ministry of SMEs and Startups for research and development and marketing over the next two years. This was done with the investment of the Incheon Intellectual Property No. 2 Fund, which was created with the support of the Incheon Metropolitan Government, and the recommendation of the Incheon Center, the tip operator.
J&J Tech is a company based in Incheon, and CEO Cho Sung-hoon developed a drug recognition and inventory management solution to solve the difficulties of drug inventory management that pharmacists are experiencing in the field based on his experience as a pharmacist for 10 years.
Based on this, the company has developed a drug manager app that utilizes artificial intelligence (AI) object recognition technology. The app provides drug count, return and inventory management services, and has attracted more than 10,000 customers in just three months after its launch. The Incheon Setter explained that J&J Tech's selection of the tips is the result of recognizing the capabilities of such a drug total management solution technology.
"Based on this selection of tips, we will focus more on developing solutions aimed at improving the efficiency of pharmacy work in the future," said Cho Sung-hoon, CEO of J&J Tech. "This will soon help patients and their caregivers' safety and health, and we will provide services that can be applied to the global market in the future."
Lee Han-seop, head of the Incheon Center, said, "The center judged that J&J Tech has the potential to grow into a global start-up company in the current situation where the size of the drug market continues to expand due to aging."